Table 2 Baseline treatment of patients
From: Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study
Treatment at admission | Third month treatment | |
|---|---|---|
Metformin, n (%) | 42 (100) | 42 (100) |
DPP-4 inhibitors, n (%) | 22 (52.4) | 28 (66) |
Sulphonylurea, n (%) | 10 (23.8) | 7 (16.6) |
SGLT- 2 inhibitors, n (%) | 9 (21.4) | 21 (50) |
Glinide, n (%) | 2 (4.8) | 1 (2.3) |
Basal insulin, n (%) | 36 (85.7) | 40 (95) |
Regular Insulin, n (%) | 22 (52.4) | 31 (73.8) |